PharmaCyte Biotech, Inc. (PMCB)
0.4865
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Shareholders Equity (Quarterly) : 34.56M for April 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 34.56M |
| January 31, 2026 | 38.99M |
| October 31, 2025 | 36.14M |
| July 31, 2025 | 43.59M |
| April 30, 2025 | 51.89M |
| January 31, 2025 | 40.25M |
| October 31, 2024 | 43.45M |
| July 31, 2024 | 53.04M |
| April 30, 2024 | 39.51M |
| January 31, 2024 | 48.89M |
| October 31, 2023 | 58.07M |
| July 31, 2023 | 59.48M |
| April 30, 2023 | 72.69M |
| January 31, 2023 | 77.12M |
| October 31, 2022 | 81.04M |
| July 31, 2022 | 86.30M |
| April 30, 2022 | 89.92M |
| January 31, 2022 | 91.33M |
| October 31, 2021 | 92.12M |
| July 31, 2021 | 5.712M |
| April 30, 2021 | 6.680M |
| January 31, 2021 | 7.613M |
| October 31, 2020 | 8.277M |
| July 31, 2020 | 6.245M |
| April 30, 2020 | 5.089M |
| Date | Value |
|---|---|
| January 31, 2020 | 4.319M |
| October 31, 2019 | 4.534M |
| July 31, 2019 | 5.000M |
| April 30, 2019 | 5.040M |
| January 31, 2019 | 5.366M |
| October 31, 2018 | 5.404M |
| July 31, 2018 | 6.198M |
| April 30, 2018 | 5.769M |
| January 31, 2018 | 5.838M |
| October 31, 2017 | 7.348M |
| July 31, 2017 | 8.659M |
| April 30, 2017 | 8.087M |
| January 31, 2017 | 7.037M |
| October 31, 2016 | 6.283M |
| July 31, 2016 | 7.067M |
| April 30, 2016 | 6.523M |
| January 31, 2016 | 6.936M |
| October 31, 2015 | 6.898M |
| July 31, 2015 | 7.829M |
| April 30, 2015 | 7.777M |
| January 31, 2015 | 6.248M |
| October 31, 2014 | 6.382M |
| July 31, 2014 | 7.827M |
| April 30, 2014 | 8.942M |
| January 31, 2014 | 5.233M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 46.75M |
| Total Liabilities (Quarterly) | 11.77M |
| Current Ratio | 45.28 |